Neuronetics, Inc. (NASDAQ: STIM) is a Healthcare company (Medical - Devices) with a market capitalization of $99M. The Maz Rating grades it against the other companies in its sector.
Neuronetics, Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $1.28, Neuronetics, Inc. trades at 0.6x sales and 5.2x book value. Over the last twelve months it generated about $160M of revenue and a net loss of $25M. It runs a gross margin of 50.7%, an operating margin of -9.4% and a net margin of -14.4%. It shows return on equity of -127.9%, return on invested capital of -13.6% and a free cash flow yield of -8.4%. On the balance sheet: a debt-to-equity ratio of 4.69 and a current ratio of 2.01. Over the past 52 weeks the share price ranged from $0.80 to $3.44, with a beta of 1.20.
Neuronetics, Inc. does not currently pay a dividend.
8 Wall Street analyst ratings cover the stock: 7 Buy and 1 Hold, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.